✦ LIBER ✦

Morphometric analysis of corneal endothelium after intravitreal ranibizumab (Lucentis®) in age-related macular degeneration treatment

✍ Scribed by J. Benítez-Herreros; C. Pérez-Rico; M.A. Teus; Y. Gómez-San Gil; M. Castro-Rebollo

Book ID: 119649031
Publisher: Elsevier
Year: 2010
Weight: 323 KB
Volume: 85
Category: Article
ISSN: 2173-5794
DOI: 10.1016/s2173-5794(10)70053-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical outcomes after switching treatm

Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration

✍ Heussen, Florian M.; Shao, Qing; Ouyang, Yanling; Joussen, Antonia M.; Müller, B 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 478 KB

Comparison of outcomes after switching t

Comparison of outcomes after switching treatment from intravitreal bevacizumab to ranibizumab in neovascular age-related macular degeneration

✍ Kent, Jerrod S.; Iordanous, Yiannis; Mao, Alex; Powell, Anne-Marie; Kent, Shefal 📂 Article 📅 2012 🏛 Canadian Ophthalmological Society 🌐 English ⚖ 196 KB

Predictors of 1-year visual outcome in n

Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatment

✍ Sara B. Bloch; Morten la Cour; Birgit Sander; Louise K. H. Hansen; Josefine Fuch 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 222 KB

Short-term changes of visual hallucinati

Short-term changes of visual hallucinations after intravitreal injection of ranibizumab in neovascular age-related macular degeneration

✍ Mitrut, I; Chua, P; Aslam, T; Vani, A; Ambrecht, A M; Dhillon, B 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 74 KB

A randomised prospective double-masked e

A randomised prospective double-masked exploratory study comparing combination photodynamic treatment and intravitreal ranibizumab vs intravitreal ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration

✍ Vallance, J H; Johnson, B; Majid, M A; Banerjee, S; Mandal, K; Bailey, C C 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 433 KB

PSS13 COST-EFFECTIVE ANALYSIS OF PEGAPTA

PSS13 COST-EFFECTIVE ANALYSIS OF PEGAPTANIB (MACUGEN®) AS COMPARED WITH RANIBIZUMAB (LUCENTIS®) FOR TREATING IN AGE-RELATED MACULAR DEGENERATION (AMD)

✍ LY Lu; W McGhan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB